These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38471435)

  • 1. Longitudinal prognosis of Parkinson's outcomes using causal connectivity.
    Mellema CJ; Nguyen KP; Treacher A; Andrade AX; Pouratian N; Sharma VD; O'Suileabhain P; Montillo AA
    Neuroimage Clin; 2024; 42():103571. PubMed ID: 38471435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
    Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
    Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes.
    Burciu RG; Chung JW; Shukla P; Ofori E; Li H; McFarland NR; Okun MS; Vaillancourt DE
    Neurology; 2016 Aug; 87(7):709-17. PubMed ID: 27421545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
    Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
    Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
    Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
    Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
    Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of meta-analytical functional connectivity in progressive supranuclear palsy.
    Yu F; Barron DS; Tantiwongkosi B; Fox M; Fox P
    Clin Radiol; 2018 Apr; 73(4):415.e1-415.e7. PubMed ID: 29269038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease.
    Zeighami Y; Fereshtehnejad SM; Dadar M; Collins DL; Postuma RB; Dagher A
    Neuroimage Clin; 2019; 24():101986. PubMed ID: 31514113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient level.
    Baggio HC; Abos A; Segura B; Campabadal A; Uribe C; Giraldo DM; Perez-Soriano A; Muñoz E; Compta Y; Junque C; Marti MJ
    Neuroimage Clin; 2019; 22():101720. PubMed ID: 30785051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.